Researchers are one step closer to developing eye drops to treat common sight loss condition

23 July 2018
Source: University of Birmingham

Scientists at the University of Birmingham are one step closer to developing an eye drop that University of Birmingham Logocould revolutionise treatment for age-related macular degeneration (AMD).

AMD is the leading cause of blindness in the developed world. Its prevalence is increasing dramatically as the population ages and it is estimated that, by 2020, there will be about 200 million people worldwide with the condition. In the UK alone, there are over 500,000 people with late stage AMD.

Read the full story on the University of Birmingham Website

Related Posts

  • RNIB: Sight loss adviser animation

    9 June 2015

    RNIB have just just launched their new sight loss animation:

  • KAB: Sight Matters 2015

    1 April 2015

    Venue: Trinity Resource Centre, St Mary's Avenue, Margate, Kent CT9 3TN Date: October 28th 2015 10.00 - 15.00 A free exhibition showcasing services and equipment…

  • Papers for the Vision UK Dementia & Sight Loss Committee

    24 October 2017

    Please find attached the papers for the Vision UK Dementia & Sight Loss Committee, the details of which are as follows: Date: 1 November 2017…